...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: A taxable versus a non taxable sale

..taxable??,,,,,,,,there has to be a transaction first.....it must be assumed that ZEL is to be sold lock, stock and barrel and will not be listed on an exchange! And it will probably make no difference what we value the asset at,  it was a spin off so I assume 0 dollars is the starting point for appreciation on any disposition. jmo

Share
New Message
Please login to post a reply